The role of lifestyle intervention in the high risk patient
Two sides to the story: clearance in Alzheimer’s disease
Neuroinflammatory insults and neurodenegeration
Late and early-onset AD: understanding the differences
Treating dementia: where should we focus?
Pieter Jelle Visser